Site US00122 — Greensboro, North Carolina

Site US00122 is a clinical research site located in Greensboro, North Carolina, United States 27403.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US00122 has participated in 1 clinical trials.

Therapeutic areas: Overactive Bladder (OAB).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00122?

Site US00122 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00122 conducted?

Site US00122 has 1 clinical trials on record. Their work covers Overactive Bladder (OAB).

Is Site US00122 accredited by Crixeo Health?

Site US00122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.